Usefulness of CTC and DTC-BM Detection for Adjuvant Therapy Effects and Prognosis Prediction in Early Breast Carcinoma: Results of 8–11 Years of Follow-up Evaluation-Reference-Cited by-同舟云学术

Usefulness of CTC and DTC-BM Detection for Adjuvant Therapy Effects and Prognosis Prediction in Early Breast Carcinoma: Results of 8–11 Years of Follow-up Evaluation

Published:2016-12-01 Issue:5 Volume:24 Page:1227-1233
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Takeyama Hiroshi,Shimada T.,Kinoshita S.,Uchida K.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-016-5714-1.pdf

Reference27 articles.

1. Tsukuma H, Ajiki W, Ioka A, Oshima A. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. Research Group of Population-Based Cancer Registries of Japan. Jpn J Clin Oncol. 2006;36:602–7.

2. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2003;24:2910–16.

3. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;25(353):793–802.

4. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781–91.

5. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res. 2006;12:4218–24.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities;Seminars in Cancer Biology;2022-01

2. Disseminated tumor cells in bone marrow of cancer patients;Bone Cancer;2022

3. Brief Summary and Perspectives for CTCs;Atlas of Liquid Biopsy;2021

4. Biomarkers detecting minimal residual disease in solid tumors: what do they mean in the clinical management of patients?;Biomarkers in Medicine;2019-12

5. Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse;ecancermedicalscience;2019-06-27